Liu X - Search Results

1

Novel Therapeutic Potential of Retinoid-Related Orphan Receptor α in Cardiovascular Diseases.

Chen Y, Zhang SP, Gong WW, Zheng YY, Shen JR, Liu X, Gu YH, Shi JH, Meng GL. Chen Y, et al. Among authors: liu x. Int J Mol Sci. 2023 Feb 9;24(4):3462. doi: 10.3390/ijms24043462. Int J Mol Sci. 2023. PMID: 36834872 Free PMC article. Review.

2

Protective role of sirtuin3 against oxidative stress and NLRP3 inflammasome in cholesterol accumulation and foam cell formation of macrophages with ox-LDL-stimulation.

Ding Y, Gong W, Zhang S, Shen J, Liu X, Wang Y, Chen Y, Meng G. Ding Y, et al. Among authors: liu x. Biochem Pharmacol. 2021 Oct;192:114665. doi: 10.1016/j.bcp.2021.114665. Epub 2021 Jun 25. Biochem Pharmacol. 2021. PMID: 34181898

3

Protective role of hydrogen sulfide against diabetic cardiomyopathy via alleviating necroptosis.

Gong W, Zhang S, Chen Y, Shen J, Zheng Y, Liu X, Zhu M, Meng G. Gong W, et al. Among authors: liu x. Free Radic Biol Med. 2022 Mar;181:29-42. doi: 10.1016/j.freeradbiomed.2022.01.028. Epub 2022 Jan 29. Free Radic Biol Med. 2022. PMID: 35101564

4

Roles of the adaptor protein tumor necrosis factor receptor type 1-associated death domain protein (TRADD) in human diseases.

Chen Y, Gu Y, Xiong X, Zheng Y, Liu X, Wang W, Meng G. Chen Y, et al. Among authors: liu x. Biomed Pharmacother. 2022 Sep;153:113467. doi: 10.1016/j.biopha.2022.113467. Epub 2022 Jul 28. Biomed Pharmacother. 2022. PMID: 36076575 Free article. Review.

5

Novel Ru(II) Complexes as Type-I/-II Photosensitizers for Multimodal Hypoxia-Tolerant Chemo-Photodynamic/Immune Therapy.

Liu X, Zheng H, Peng Y, Ji D, Wang C, Wang D, Jia Z, Chang Y, Cai X, Wang L, Ling Y. Liu X, et al. Mol Pharm. 2025 Jan 4. doi: 10.1021/acs.molpharmaceut.4c01046. Online ahead of print. Mol Pharm. 2025. PMID: 39754739

6

Novel tris-bipyridine based Ru(II) complexes as type-I/-II photosensitizers for antitumor photodynamic therapy through ferroptosis and immunogenic cell death.

Zheng H, Wang K, Ji D, Liu X, Wang C, Jiang Y, Jia Z, Xiong B, Ling Y, Miao J. Zheng H, et al. Among authors: liu x. Eur J Med Chem. 2024 Dec 5;279:116909. doi: 10.1016/j.ejmech.2024.116909. Epub 2024 Sep 24. Eur J Med Chem. 2024. PMID: 39357314

7

Research progress of prodrugs for the treatment of cerebral ischemia.

Zheng H, Wu H, Wang D, Wang S, Ji D, Liu X, Gao G, Su X, Zhang Y, Ling Y. Zheng H, et al. Among authors: liu x. Eur J Med Chem. 2024 Jun 5;272:116457. doi: 10.1016/j.ejmech.2024.116457. Epub 2024 May 1. Eur J Med Chem. 2024. PMID: 38704941 Review.

8

Iron-Based Theranostic Nanoplatform for Improving Chemodynamic Therapy of Cancer.

Liu X, Jin Y, Liu T, Yang S, Zhou M, Wang W, Yu H. Liu X, et al. Among authors: liu t. ACS Biomater Sci Eng. 2020 Sep 14;6(9):4834-4845. doi: 10.1021/acsbiomaterials.0c01009. Epub 2020 Aug 25. ACS Biomater Sci Eng. 2020. PMID: 33455215 Review.

9

Stimuli-activatable nanomaterials for phototherapy of cancer.

Zhou M, Liu X, Chen F, Yang L, Yuan M, Fu DY, Wang W, Yu H. Zhou M, et al. Among authors: liu x. Biomed Mater. 2021 May 10;16(4). doi: 10.1088/1748-605X/abfa6e. Biomed Mater. 2021. PMID: 33882463 Review.

10

Stimuli-Sheddable Nanomedicine Overcoming Pathophysiological Barriers for Potentiating Immunotherapy of Cancer.

Wang J, Zhou M, Chen F, Liu X, Gao J, Wang W, Wang H, Yu H. Wang J, et al. Among authors: liu x. J Biomed Nanotechnol. 2021 Aug 1;17(8):1486-1509. doi: 10.1166/jbn.2021.3134. J Biomed Nanotechnol. 2021. PMID: 34544528

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

138,161 results

Search Page

Filters